Important new resource for alcohol use disorder education! Check it out!

Check it out our first video about medications for AUD: learning.pcss-maud.org/mini-videos Yale Program in Addiction Medicine Yale Internal Medicine more to come soon!

Thanks all who attended addiction medicine grand rounds today! We hope to see you again on 5/28, when Shawn Cohen will join a panel of experts in discussion around advancing MOUD access in skilled nursing facilities.

🔗yalesurvey.ca1.qualtrics.com/jfe/form/SV_37…

🚨New Study! We're enrolling participants in the pilot phase of an OUD Telehealth Study at Yale School of Medicine Yale Emergency Medicine, led by Drs Rebekah Heckmann & Nasim
If you or someone you know uses opioids you may be eligible to connect w recovery coaches & providers via telehealth 1/3

Yale Internal Medicine's top stories of 2023 include our very own Dr. Melissa Weimer & team rolling out take-home #methadone for OUD at Yale New Haven Hosp on the Yale Addiction Medicine Consult Service. Read about it here: medicine.yale.edu/internal-medic…

Check out this easy to read paper📝on how to address OUD in hospitalized patients, in-hospital substance use, and advocate for your patients.🙌🏼 #hospitalists

Read more: bit.ly/3t8EY9U

@calcaterrasusan @drmelissaweimer @drmeganburesh @hospmedicine

Proud to see this paper in print. Shout it from the rooftops - in real world data MOUD (methadone & buprenorphine) reduce overdose risk and non-MOUD addiction treatments (inpatient, detox) do not. MOUD should always be first line for people with severe OUD. Yale Program in Addiction Medicine

Great discussion per ⁦Dr. Melissa Weimer⁩ of considerations for starting #bup with high dose synthetic opioids Special Episode: ASAM Clinical Considerations: Buprenorphine Treatment of Opioid Use Disorder | This Week in Addiction Medicine from ASAM …isweekinaddictionmedicine.podbean.com/e/special-epis…

Incredibly helpful thread from one of my heroes.

Helpful tips for changing buprenorphine rx practices in the era of fentanyl from Carolyn Chan MD

1/8 High potency synthetic opioids (HPSO; aka fentanyl + analogs) have changed the MOUD treatment strategies & research hasn’t had time to catch up to the change in drug supply.

What’s a clinician to do❓

(3/3) Learn more about safer substance use practices, including strategies for reducing risk of HCV and other infections when injecting, by visiting safersubstanceuse.org

Newly published (AEM Journal), Gail D'Onofrio et al report on ~800 ED patients with opioid use disorder who received a 7-day injectable preparation of extended-release buprenorphine between 6/2020-7/2023. pubmed.ncbi.nlm.nih.gov/37501652/

☀️Hot off the press: ☀️ ⁦ASAM⁩ Clinical Considerations: Buprenorphine Treatment of Opi... : Journal of Addiction Medicine ⁦Journal of Addiction Medicine⁩ journals.lww.com/journaladdicti…

Better education for patients and clinicians is so important - amazing resource!

#TwitteRx “Throw a couple of alcohol swabs in the bag with the syringes.” As simple as that, American Pharmacists Association Next, learn more and read this guide!

Knowledge is powerful prevention: At Safersubstanceuse.org an educational video featuring ⁦Yale School of Medicine⁩ faculty about safer injection practice, what is infective endocarditis (IE), risks for IE & treatment ⁦Yale Internal Medicine⁩ ⁦Yale Cardiac Surgery⁩ youtu.be/9uYCFOpDoR4

This is an amazing resource, would highly recommend for all interns who are just starting and new ID fellows so you can help to counsel your patients with substance use disorder

Amazing harm reduction resource!

Excited to share our completed website: safersubstanceuse.org 🌟 Grateful to the PWID & clinicians who contributed to it! Thank you also Yale New Haven Hosp Medical Staff fund for supporting it!! Kim Sue, MD, PhD Carolyn Chan MD Yale Program in Addiction Medicine